| 1 | [SID115950076] | Active | AC50 | 0.559 | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity [AID540354, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 115950076 | | CID | 20876331 | | Outcome | Active | | AC50 | 0.559 [uM] | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity | | AID | 540354 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49714924] | Active | AC50 | 1.696 | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_CherryPick_Activity [AID493194, Type: confirmatory] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | AC50 | 1.696 [uM] | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_CherryPick_Activity | | AID | 493194 | | BioAssay type | confirmatory | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 3 | [SID115950076] | Active | AC50 | 6.52 | HDL Orthogonal Assay: Alexa 488-HDL Measured in Cell-Based System Using Plate Reader - 2085-03_Inhibitor_Dose_DryPowder_Activity [AID588777, Type: confirmatory] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 115950076 | | CID | 20876331 | | Outcome | Active | | AC50 | 6.52 [uM] | | BioAssay | HDL Orthogonal Assay: Alexa 488-HDL Measured in Cell-Based System Using Plate Reader - 2085-03_Inhibitor_Dose_DryPowder_Activity | | AID | 588777 | | BioAssay type | confirmatory | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 4 | [SID49714924] | Active | Potency | 12.9953 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 5 | [SID49714924] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID49714924] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49714924] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID49714924] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 9 | [SID49714924] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 10 | [SID49714924] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 11 | [SID49714924] | Active | | | Second counter screen for compounds that modulate the two-pore domain potassium channel (KCNK9) [AID492997, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Second counter screen for compounds that modulate the two-pore domain potassium channel (KCNK9) | | AID | 492997 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 12 | [SID49714924] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 [AID488922, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 | | AID | 488922 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 13 | [SID49714924] | Active | | | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) [AID492992, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) | | AID | 492992 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 14 | [SID49714924] | Active | | | Luminescence Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301 [AID2716, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Active | | BioAssay | Luminescence Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301 | | AID | 2716 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID49714924] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID49714924] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 17 | [SID49714924] | Inactive | Potency | 6.3096 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID49714924] | Inactive | Potency | 11.2202 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 19 | [SID49714924] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID49714924] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 21 | [SID49714924] | Inactive | Potency | 35.4813 | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding [AID2675, Type: confirmatory] | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding | | AID | 2675 | | BioAssay type | confirmatory | | Target | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] | | PubMed | | | Data Table |  |
|
| 22 | [SID49714924] | Inactive | Potency | 50.1187 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 23 | [SID49714924] | Inactive | Potency | 56.2341 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 24 | [SID49714924] | Inactive | Potency | 56.2341 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 25 | [SID115950076] | Inactive | AC50 | 70 | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity_Set5 [AID602126, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 115950076 | | CID | 20876331 | | Outcome | Inactive | | AC50 | 70 [uM] | | BioAssay | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity_Set5 | | AID | 602126 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID49714924] | Inactive | Potency | 79.4328 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 27 | [SID49714924] | Inactive | Potency | 79.4328 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 28 | [SID49714924] | Inactive | AC50 | 420 | Luminescence Whole-Organism Secondary Assay to Identify Compounds Inducing Growth of Temperature Sensitive Mutant Burl-1 [AID463199, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | AC50 | 420 [uM] | | BioAssay | Luminescence Whole-Organism Secondary Assay to Identify Compounds Inducing Growth of Temperature Sensitive Mutant Burl-1 | | AID | 463199 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID49714924] | Inactive | AC50 | 420 | Luminescence Whole-Organism Dose Retest to Confirm Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301 [AID463204, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | AC50 | 420 [uM] | | BioAssay | Luminescence Whole-Organism Dose Retest to Confirm Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301 | | AID | 463204 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID49714924] | Inactive | | | Phenotypic HTS multiplex for antifungal efflux pump inhibitors [AID485275, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Phenotypic HTS multiplex for antifungal efflux pump inhibitors | | AID | 485275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID49714924] | Inactive | Potency | | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion [AID485298, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion | | AID | 485298 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID49714924] | Inactive | | | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity [AID488862, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488862 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID49714924] | Inactive | IC50 | | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis [AID488890, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis | | AID | 488890 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID49714924] | Inactive | IC50 | | Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis [AID488966, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis | | AID | 488966 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49714924] | Inactive | AC50 | | SUMO pathway Measured in Whole Organism System Using Plate Reader - 2059-03_Inhibitor_Dose_CherryPick_Activity [AID493004, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | AC50 | [uM] | | BioAssay | SUMO pathway Measured in Whole Organism System Using Plate Reader - 2059-03_Inhibitor_Dose_CherryPick_Activity | | AID | 493004 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID49714924] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling [AID493014, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling | | AID | 493014 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID49714924] | Inactive | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID49714924] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID49714924] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID49714924] | Inactive | IC90 | | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434955, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | IC90 | [uM] | | BioAssay | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics | | AID | 434955 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID49714924] | Inactive | | | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435003, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435003 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID49714924] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID49714924] | Inactive | | | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation [AID435022, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation | | AID | 435022 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID49714924] | Inactive | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID49714924] | Inactive | IC50 | | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID49714924] | Inactive | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID49714924] | Inactive | | | MLPCN Ras selective lethality-BJeLR viability [AID1554, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | MLPCN Ras selective lethality-BJeLR viability | | AID | 1554 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID49714924] | Inactive | IC50 | | A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus [AID1621, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus | | AID | 1621 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID49714924] | Inactive | | | High Throughput Imaging Assay for Hepatic Lipid Droplet Formation [AID1656, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | High Throughput Imaging Assay for Hepatic Lipid Droplet Formation | | AID | 1656 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID49714924] | Inactive | | | MLPCN Platelet Activation -Dense Granule Release [AID1663, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49714924 | | CID | 20876331 | | Outcome | Inactive | | BioAssay | MLPCN Platelet Activation -Dense Granule Release | | AID | 1663 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|